ESRP2 and hepatocellular carcinoma: GSEA analysis showed that tumors with low ESRP2 expression exhibited enrichment of genes associated with EMT and MAPK signaling (Figure 4B), suggesting that ESRP2 may be involved in controlling the MAPK pathway to affect HCC progression.